Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-02-08 @ 5:23 AM
Study NCT ID:
NCT02055118
Status:
COMPLETED
Last Update Posted:
2021-06-11
First Post:
2014-01-17
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment
Sponsor:
Shire
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Hunter Syndrome | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | hunters disease | View |
| None | MPS II | View |
| None | lysosomal storage disorder | View |
| None | hunters syndrome | View |
| None | ert treatment | View |
| None | hunter's disease | View |
| None | iduronate sulfatase | View |
| None | MPS society | View |
| None | mps 2 | View |
| None | enlarged adenoids | View |
| None | hunter's syndrome | View |
| None | iduronate 2 sulfatase | View |
| None | chronic ear infection | View |
| None | mucopolysaccharides | View |
| None | hunter syndrome therapy | View |
| None | hunter's syndrome treatment | View |
| None | enzyme replacement therapy | View |
| None | hunter syndrome treatment | View |
| None | elaprase | View |
| None | MPSII | View |
| None | lysosomal storage disease | View |
| None | mps diagnosis | View |
| None | mps symptoms | View |
| None | idursulfase | View |
| None | hunter disease | View |
| None | hunter's disease treatment | View |
| None | MPS2 | View |